Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • wentingting
    Member
    • Sep 2012
    • 15

    #1

    Join Us for ICG-9 & SIBIFE-3

    Joint Conference of the 9th International Conference on Genomics and the 3rd Shenzhen International Biotechnology Innovation Forum & Expo


    September 9-12, 2014

    Shenzhen Convention & Exhibition Center, Shenzhen, China
    www.icg9-sibife.org


    ICG-9 & SIBIFE-3

    The Convergence of ICG-9 and SIBIFE-3
    In 2014, the 9th International Conference on Genomics (ICG-9) and the 3rd Shenzhen International Biotechnology Innovation Forum & Expo (SIBIFE-3) will join forces to stage one of the world’s most influential and fruitful annual conferences for the genomics and life science industries. It will bring together a diverse group of attendees and provide a platform to discuss recent advances and establish new collaborations. Shenzhen is one of the most energetic and fast-developing cities in the world. With strong support from open-minded local government and ample resources; the city provides a friendly environment for innovators and entrepreneurs.

    ICG
    ICG aims at gathering leaders, researchers and professionals in omics sciences on human health, animal and plant science, agriculture and other related fields, to share thoughts and implications on the latest developments in the world of genomics. Since its inauguration 9 years ago, ICG has proved itself as one of the most dynamic, enthusiastic, and enjoyable gatherings internationally. We have not only been doing science, we have also been cultivating a culture of collaboration. ICG puts everyone together, to do together, to share together and lets communication make a difference.

    SIBIFE
    SIBIFE is one of the largest and most influential events in the region with a focus on promoting academic communication, development of new businesses, and industrialization of global biotechnology research and translation. In 2013, the 2nd SIBIFE brought together more than 1,200 policy makers, corporate leaders, industry heavyweights, biotech investors and insightful scholars. This year, SIBIFE will inaugurate the 1st BT Leaders Summit, where presenters will share their insights on building a global connection between advanced biotechnology and capital to promote innovation and inspiration for sustainable biotechnology and healthcare industries.

    The convergence of ICG and SIBIFE this year will gather even more friends together from the globe and provide exciting opportunities to develop greater collaborations between scientists and industry professionals in omics world. This joint conference will be a dynamic, enthusiastic, and enjoyable gathering for everyone, and it is a great pleasure to have you with us.

    Conference Tracks
    ICG-9
    Ancient and Extinct Genomes
    Evolution and Biodiversity
    Rare Diseases
    Reproductive Health
    Orphan Crops
    Major Crops
    Soybean Genomics
    Complex Diseases
    Cancer Genomics
    Virus Screen
    Science and Society
    Bioinformatics and Big Data Solutions
    Publication
    Animal Population Genetics
    Metabonomics and Proteomics
    Metagenomics

    SIBIFE-3
    BT Leaders Summit
    When will Bio-economy come?
    Future of BT+IT
    Innovation Forum
    International Bio Bay Infrastructure
    Partnership and Investment
    Global Initiative on Biobanking
    New Agricultural Economy
    Personalized Healthcare

    Registration
    Early Bird Discount Available! Register before May 28, 2014 and Save 260 USD.

    For more information about this joint conference, please visit www.icg9-sibife.org.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Today, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...